+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vascular Closure Device Market - Global Forecast 2026-2032- Product Image
Vascular Closure Device Market - Global Forecast 2026-2032- Product Image
Sale

Vascular Closure Device Market - Global Forecast 2026-2032

  • Report

  • 187 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5460268
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Vascular Closure Device Market is projected to reach USD 2.00 Billion in 2026. It is expected to continue growing at a CAGR of 7.71%, reaching USD 3.11 Billion by 2032.

The vascular closure device market is expanding as hospitals seek faster, safer hemostasis after catheter-based cardiovascular, peripheral vascular, and structural heart procedures. These devices close arterial access sites after femoral and other vascular punctures, reducing time to hemostasis and ambulation compared with prolonged manual compression in appropriately selected patients.

Demand is supported by the global cardiovascular disease burden: the World Health Organization identifies cardiovascular disease as the leading cause of death worldwide, responsible for an estimated 17.9 million deaths in 2019. Adoption is also tied to minimally invasive interventions, aging populations, day-case catheterization pathways, and continued use of femoral access for large-bore procedures such as transcatheter aortic valve replacement, endovascular aneurysm repair, and mechanical circulatory support.

Transformative Shifts in the Vascular Closure Landscape

The vascular closure device landscape is being reshaped by access-site strategy, procedural complexity, and hospital efficiency goals. Radial access has reduced femoral use in many coronary interventions because clinical evidence and professional guidelines associate radial percutaneous coronary intervention with fewer bleeding and vascular complications in suitable patients. However, femoral artery closure remains essential for large-bore and complex procedures where radial access is not feasible.

Technology development is advancing across suture-mediated, collagen-based, clip-based, plug-based, and resorbable closure systems designed for predictable hemostasis, lower complication risk, and compatibility with larger sheath sizes. Hospitals are also standardizing ultrasound-guided access, anticoagulation protocols, and same-day discharge workflows, making device reliability, clinical evidence, and operator training central purchasing criteria.

Cumulative Impact of Artificial Intelligence on Closure Devices

Artificial intelligence is beginning to influence the vascular closure device market through the broader interventional care pathway rather than through closure alone. The U.S. Food and Drug Administration’s public list of AI/ML-enabled medical devices has expanded rapidly, demonstrating accelerating clinical adoption of artificial intelligence in imaging, diagnostics, workflow optimization, and procedural support.

In vascular access management, AI can support pre-procedure risk stratification, vessel assessment from ultrasound or CT imaging, prediction of bleeding and access-site complications, and post-procedure surveillance. For suppliers, AI-enabled analytics can improve inventory planning, complaint trending, training effectiveness, quality systems, and real-world evidence generation. Adoption must remain clinically validated, transparent, and aligned with data privacy and medical device regulatory requirements.

Key Regional Insights Across Global Vascular Closure Demand

North America remains a high-value region for vascular closure devices due to advanced catheterization laboratory infrastructure, strong adoption of percutaneous coronary intervention, transcatheter aortic valve replacement, peripheral interventions, and established regulatory pathways through the U.S. Food and Drug Administration and Health Canada. Europe is shaped by mature interventional cardiology networks and the EU Medical Device Regulation, which raises expectations for clinical evidence, post-market surveillance, quality management, and device traceability.

Asia-Pacific is gaining momentum as China, India, Japan, South Korea, and Australia expand cardiovascular procedure capacity, specialist training, and hospital infrastructure. Latin America, led by Brazil and Mexico, shows steady demand for femoral artery closure and hemostasis management, although reimbursement, procurement, and access remain uneven across public and private systems. The Middle East is investing in specialty cardiac centers, particularly in Gulf economies with national health transformation programs, while Africa remains earlier-stage, with adoption tied to catheterization laboratory availability, clinician training, public-private investment, and broader access to interventional cardiovascular care.

Key Group Insights for Market Prioritization

ASEAN markets are benefiting from cardiovascular infrastructure investment, medical tourism, and growing private hospital networks, although procurement remains fragmented by country and varies with reimbursement maturity. GCC demand is supported by national health transformation programs, high cardiometabolic disease prevalence documented by regional public health authorities, and investment in tertiary cardiac care, making reliable vascular access closure important for efficient cath lab throughput.

The European Union creates a harmonized but more demanding compliance environment under the Medical Device Regulation, favoring suppliers with strong clinical documentation, post-market clinical follow-up, and quality systems. BRICS markets combine large patient populations, expanding cardiovascular care capacity, and cost sensitivity, making local partnerships, education, and tiered access strategies important. G7 countries remain innovation-led and evidence-driven, while NATO member markets often overlap with advanced hospital systems that increasingly emphasize supply-chain resilience, standardized clinical readiness, and compliant medical device procurement.

Key Country Insights in the Vascular Closure Device Market

The United States is a core market due to high interventional procedure volumes, outpatient migration, broad use of advanced structural heart techniques, and established pathways for medical device clearance and surveillance. Canada emphasizes safety, value, provincial procurement discipline, and clinical evidence. Mexico and Brazil present expanding opportunities through private hospitals, cardiovascular infrastructure development, and improving access to interventional cardiology, while reimbursement variability continues to influence adoption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from established catheterization laboratory networks, evidence-based purchasing, and growing demand for efficient post-procedure recovery. Russia places greater emphasis on localization, regulatory continuity, and supply security. In Asia-Pacific, China and India offer scale and rising cardiovascular procedure volumes, Japan prioritizes quality and safety for an aging population, Australia maintains high clinical and regulatory standards, and South Korea combines advanced technology adoption with strong hospital capabilities and specialist interventional expertise.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical differentiation supported by real-world evidence, including time to hemostasis, time to ambulation, access-site complication rates, large-bore closure performance, patient selection, and total cost of care. Devices that integrate smoothly with ultrasound-guided access, anticoagulated patients, and same-day discharge protocols are better positioned for hospital adoption.

Suppliers should strengthen physician training, simulation programs, proctoring, and post-market surveillance while tailoring value propositions by region. In mature markets, health economics, regulatory compliance, and FDA- or MDR-quality evidence are decisive. In emerging markets, affordability, distributor quality, local service, and clinical education drive access. AI-enabled analytics should be used to improve quality systems, demand planning, training impact measurement, and outcomes evidence without overstating unvalidated clinical claims.

Research Methodology and Evidence Base

This executive summary applies a secondary research methodology using publicly available and institutionally recognized sources, including the World Health Organization, U.S. Food and Drug Administration, OECD health indicators, national cardiovascular and regulatory agencies, peer-reviewed interventional cardiology literature, clinical guidelines, and medical device regulatory frameworks.

Insights were triangulated across cardiovascular disease burden, procedure trends, access-site practice patterns, reimbursement environment, regulatory requirements, technology adoption, and hospital workflow priorities. The analysis emphasizes verified directional evidence rather than unsupported market sizing claims, ensuring that conclusions on vascular closure devices, femoral artery closure, large-bore closure, and hemostasis management remain defensible for strategic decision-making.

Conclusion: Strategic Outlook for Vascular Closure Devices

The vascular closure device market is positioned for sustained relevance as minimally invasive cardiovascular and endovascular procedures grow worldwide. While radial access has changed coronary practice, femoral and large-bore access continue to require reliable closure solutions that reduce workflow burden, support patient mobility, and help hospitals standardize post-procedure recovery.

Future competitive advantage will depend on clinical evidence, operator training, regulatory excellence, post-market surveillance, and region-specific market access strategies. Organizations that demonstrate measurable safety, efficiency, and economic value will be best placed to meet demand across mature health systems and emerging healthcare markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Vascular Closure Device Market, by Product Type
7.1. Introduction
7.2. Clip Based Devices
7.3. Collagen Plug Devices
7.3.1. Bovine Collagen Plugs
7.3.2. Synthetic Collagen Plugs
7.4. External Compression Devices
7.5. Sealant Based Devices
7.5.1. Chitosan Sealants
7.5.2. Polyethylene Glycol Sealants
7.6. Suture Based Devices
8. Vascular Closure Device Market, by Procedure Type
8.1. Introduction
8.2. Diagnostic Procedures
8.2.1. Angiographic Procedures
8.2.2. Hemodynamic Monitoring
8.3. Interventional Procedures
8.3.1. Cardiovascular Interventions
8.3.2. Peripheral Vascular Interventions
9. Vascular Closure Device Market, by Access Site
9.1. Introduction
9.2. Femoral Access
9.3. Radial Access
10. Vascular Closure Device Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Vascular Closure Device Market, by Distribution Channel
11.1. Introduction
11.2. Direct Sales
11.3. Third Party Distributors
12. Vascular Closure Device Market, by Region
12.1. Asia-Pacific
12.2. North America
12.3. Latin America
12.4. Europe
12.5. Middle East
12.6. Africa
13. Vascular Closure Device Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Vascular Closure Device Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abbott Laboratories
16.2. Acandis GmbH
16.3. Advanced Vascular Dynamics
16.4. AngioDynamics Inc
16.5. Asahi Intecc Co Ltd
16.6. B Braun Melsungen AG
16.7. Biotronik SE & Co KG
16.8. Boston Scientific Corporation
16.9. Cardinal Health Inc
16.10. Cook Medical LLC
16.11. Cordis US Corp
16.12. Forge Medical Inc
16.13. Haemonetics Corporation
16.14. Inari Medical Inc
16.15. iVascular SLU
16.16. Lepu Medical Technology Beijing Co Ltd
16.17. Medtronic plc
16.18. Meril Life Sciences Pvt Ltd
16.19. Merit Medical Systems Inc
16.20. Morris Innovative Inc
16.21. Rex Medical LP
16.22. Teleflex Incorporated
16.23. Terumo Corporation
16.24. Transluminal Technologies LLC
16.25. Tricol Biomedical Inc
16.26. TZ Medical Inc
16.27. Vasorum Ltd
16.28. Vivasure Medical Ltd
16.29. W L Gore & Associates Inc
List of Figures
FIGURE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL VASCULAR CLOSURE DEVICE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 15. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL VASCULAR CLOSURE DEVICE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL VASCULAR CLOSURE DEVICE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL VASCULAR CLOSURE DEVICE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CLIP BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL COLLAGEN PLUG DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL BOVINE COLLAGEN PLUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL SYNTHETIC COLLAGEN PLUGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL EXTERNAL COMPRESSION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL SEALANT BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL CHITOSAN SEALANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL POLYETHYLENE GLYCOL SEALANTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL SUTURE BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL ANGIOGRAPHIC PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HEMODYNAMIC MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INTERVENTIONAL PROCEDURES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR INTERVENTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL PERIPHERAL VASCULAR INTERVENTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL FEMORAL ACCESS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL FEMORAL ACCESS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL FEMORAL ACCESS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL RADIAL ACCESS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL RADIAL ACCESS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL RADIAL ACCESS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL DIRECT SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL DIRECT SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL DIRECT SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL THIRD PARTY DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 85. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 87. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 88. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 89. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 90. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 95. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 96. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 97. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 98. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 99. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 105. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 107. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 108. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 109. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 110. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 111. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 112. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 113. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 114. EUROPE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 115. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 116. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 127. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 128. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 129. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 130. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 131. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 132. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 133. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 134. AFRICA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 136. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 138. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 139. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 140. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 141. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 142. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 143. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 144. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. ASEAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 146. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 149. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 150. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 151. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 152. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 153. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 154. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 155. GCC VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 164. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 165. EUROPEAN UNION VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 166. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 168. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 169. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 170. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 171. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 172. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 173. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 174. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 175. BRICS VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 176. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 177. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 178. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 179. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 180. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 181. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 182. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 183. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 184. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. G7 VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 186. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 187. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 188. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 189. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 190. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 191. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 192. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 193. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 194. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. NATO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. GLOBAL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 201. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 202. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 203. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 204. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 205. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 206. UNITED STATES VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 207. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 210. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 211. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 212. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 213. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 214. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 215. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 216. CANADA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 217. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 218. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 219. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 220. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 221. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 222. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 223. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 224. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 225. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 226. MEXICO VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 228. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 229. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 230. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 231. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 232. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 233. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 234. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 235. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. BRAZIL VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 237. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 240. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 241. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 242. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 243. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 244. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 245. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 246. UNITED KINGDOM VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 247. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 249. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 250. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 251. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 252. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 253. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 254. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 255. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 256. GERMANY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 257. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 258. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 259. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 260. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 261. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 262. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 263. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 264. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 265. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. FRANCE VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 267. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 268. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 269. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 270. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 271. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 272. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 273. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 274. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 275. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. RUSSIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 277. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 278. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 279. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 280. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 281. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 282. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 283. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 284. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 285. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 286. ITALY VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 287. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 290. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 291. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 292. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 293. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 294. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 295. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 296. SPAIN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 297. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 298. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 299. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 300. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 301. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 302. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 303. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 304. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 305. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 306. CHINA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 307. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 309. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 310. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 311. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 312. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 313. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 314. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 315. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 316. INDIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 317. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 318. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 319. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 320. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 321. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 322. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 323. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 324. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 325. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. JAPAN VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 327. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 328. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 329. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY COLLAGEN PLUG DEVICES, 2017-2032 (USD MILLION)
TABLE 330. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY SEALANT BASED DEVICES, 2017-2032 (USD MILLION)
TABLE 331. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY PROCEDURE TYPE, 2017-2032 (USD MILLION)
TABLE 332. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DIAGNOSTIC PROCEDURES, 2017-2032 (USD MILLION)
TABLE 333. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY INTERVENTIONAL PROCEDURES, 2017-2032 (USD MILLION)
TABLE 334. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY ACCESS SITE, 2017-2032 (USD MILLION)
TABLE 335. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 336. AUSTRALIA VASCULAR CLOSURE DEVICE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TA

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Advanced Vascular Dynamics
  • AngioDynamics Inc
  • Asahi Intecc Co Ltd
  • B Braun Melsungen AG
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • Cardinal Health Inc
  • Cook Medical LLC
  • Cordis US Corp
  • Forge Medical Inc
  • Haemonetics Corporation
  • Inari Medical Inc
  • iVascular SLU
  • Lepu Medical Technology Beijing Co Ltd
  • Medtronic plc
  • Meril Life Sciences Pvt Ltd
  • Merit Medical Systems Inc
  • Morris Innovative Inc
  • Rex Medical LP
  • Teleflex Incorporated
  • Terumo Corporation
  • Transluminal Technologies LLC
  • Tricol Biomedical Inc
  • TZ Medical Inc
  • Vasorum Ltd
  • Vivasure Medical Ltd
  • W L Gore & Associates Inc

Table Information

Report AttributeDetails
No. of Pages187
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 2 Billion
Forecasted Market Value ( USD ) by 2032 $ 3.11 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned29

Related Topics

Related Reports

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Vascular Closure Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Arteriotomy Closure Devices Market - Global Forecast 2026-2032 - Product Image

Arteriotomy Closure Devices Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2026-2034 - Product Image

Vascular Closure Devices Market Report by Product, Access, Procedure, End-User, and Region 2026-2034

  • Report
  • 146 Pages
  • Global
From
Wound Closure Devices Market - Global Forecast 2026-2032 - Product Image

Wound Closure Devices Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Vascular Closure Device - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Vascular Closure Device - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 115 Pages
  • Global
From

About the Vascular Closure Device Market

The Vascular Closure Device (VCD) market is a segment of the Cardiovascular Devices industry. VCDs are used to close the puncture site of a vessel after a catheterization procedure. They are designed to reduce the risk of bleeding and hematoma formation, and to reduce the time required for the patient to recover. VCDs are typically made of biocompatible materials such as polymers, metals, and fabrics. VCDs are used in a variety of cardiovascular procedures, including angioplasty, stenting, and atherectomy. They are also used in the treatment of peripheral artery disease, coronary artery disease, and other cardiovascular conditions. The VCD market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Abbott, Medtronic, Terumo, Merit Medical, and Boston Scientific. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.